AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2017

Jul 6, 2017

Director's Dealing

Opens in your device viewer

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-06-15

Reporting Person: Branson Matthew (Principal Fin & Acct Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-15	Stock Options (right to buy)	$1.53	D	15000	Disposed	2025-03-10	Common Stock (15000)	Direct
2017-06-15	Stock Options (right to buy)	$0.93	D	25000	Disposed	2026-06-21	Common Stock (25000)	Direct

F1: The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options.